Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 65178 | 43.05 |
09:34 ET | 3925 | 43.5 |
09:36 ET | 6859 | 43.42 |
09:38 ET | 4265 | 43.39 |
09:39 ET | 4974 | 43.44 |
09:41 ET | 26888 | 43.235 |
09:43 ET | 11641 | 42.85 |
09:45 ET | 702 | 42.62 |
09:48 ET | 17379 | 43.04 |
09:50 ET | 12313 | 42.9 |
09:52 ET | 38698 | 42.7 |
09:54 ET | 1305 | 43 |
09:56 ET | 5201 | 43 |
09:57 ET | 45128 | 42.97 |
09:59 ET | 5682 | 42.81 |
10:01 ET | 5550 | 42.48 |
10:03 ET | 2648 | 42.46 |
10:06 ET | 31035 | 42.465 |
10:08 ET | 18636 | 42.32 |
10:10 ET | 1325 | 42.22 |
10:12 ET | 31551 | 41.975 |
10:14 ET | 2227 | 41.8417 |
10:15 ET | 19736 | 41.2542 |
10:17 ET | 13531 | 40.72 |
10:19 ET | 17124 | 41.2 |
10:21 ET | 6533 | 41.175 |
10:24 ET | 16550 | 40.825 |
10:26 ET | 16311 | 40.41 |
10:28 ET | 2850 | 40.65 |
10:30 ET | 3000 | 41.21 |
10:32 ET | 27550 | 40.97 |
10:33 ET | 3172 | 41.005 |
10:35 ET | 16695 | 40.55 |
10:37 ET | 28835 | 41.18 |
10:39 ET | 4800 | 41.15 |
10:42 ET | 5046 | 41.115 |
10:44 ET | 20160 | 41.1341 |
10:46 ET | 7993 | 41.205 |
10:48 ET | 2374 | 41.205 |
10:50 ET | 9635 | 41.16 |
10:51 ET | 3308 | 41.18 |
10:53 ET | 4343 | 41.185 |
10:55 ET | 35997 | 41.305 |
10:57 ET | 3776 | 41.56 |
11:00 ET | 20831 | 41.395 |
11:02 ET | 3062 | 41.9 |
11:04 ET | 6794 | 41.88 |
11:06 ET | 9122 | 41.916 |
11:08 ET | 1900 | 41.81 |
11:09 ET | 5950 | 41.82 |
11:11 ET | 1771 | 41.84 |
11:13 ET | 2481 | 41.925 |
11:15 ET | 3444 | 41.705 |
11:18 ET | 24921 | 41.635 |
11:20 ET | 19095 | 41.51 |
11:22 ET | 1590 | 41.495 |
11:24 ET | 4640 | 41.56 |
11:26 ET | 800 | 41.54 |
11:27 ET | 1420 | 41.57 |
11:29 ET | 800 | 41.52 |
11:31 ET | 900 | 41.53 |
11:33 ET | 3410 | 41.54 |
11:36 ET | 1320 | 41.55 |
11:38 ET | 1543 | 41.54 |
11:40 ET | 1055 | 41.44 |
11:42 ET | 2766 | 41.25 |
11:44 ET | 30640 | 41.295 |
11:45 ET | 2775 | 41.3 |
11:47 ET | 137975 | 41.265 |
11:49 ET | 25500 | 41.25 |
11:51 ET | 11878 | 41.385 |
11:54 ET | 1000 | 41.39 |
11:56 ET | 600 | 41.3 |
11:58 ET | 54700 | 41.375 |
12:00 ET | 1400 | 41.33 |
12:02 ET | 8991 | 41.3 |
12:03 ET | 900 | 41.305 |
12:05 ET | 6525 | 41.2716 |
12:07 ET | 4618 | 41.3 |
12:09 ET | 2300 | 41.325 |
12:12 ET | 24038 | 41.38 |
12:14 ET | 2700 | 41.505 |
12:16 ET | 2861 | 41.465 |
12:18 ET | 2034 | 41.27 |
12:20 ET | 4185 | 41.17 |
12:21 ET | 800 | 41.19 |
12:23 ET | 900 | 41.19 |
12:25 ET | 3007 | 41.19 |
12:27 ET | 8466 | 41.17 |
12:30 ET | 2365 | 41.1781 |
12:32 ET | 1700 | 41.185 |
12:34 ET | 700 | 41.19 |
12:36 ET | 55591 | 40.785 |
12:38 ET | 41289 | 40.97 |
12:39 ET | 3039 | 40.96 |
12:41 ET | 1627 | 40.85 |
12:43 ET | 13124 | 41.22 |
12:45 ET | 3271 | 41.07 |
12:48 ET | 1450 | 40.88 |
12:50 ET | 15885 | 40.935 |
12:52 ET | 8409 | 40.91 |
12:54 ET | 1100 | 40.98 |
12:56 ET | 2650 | 40.75 |
12:57 ET | 2899 | 40.59 |
12:59 ET | 2113 | 40.465 |
01:01 ET | 8790 | 40.56 |
01:03 ET | 1068 | 40.5192 |
01:06 ET | 5597 | 40.13 |
01:08 ET | 3604 | 40.245 |
01:10 ET | 1850 | 40.27 |
01:12 ET | 400 | 40.25 |
01:14 ET | 6295 | 40.02 |
01:15 ET | 42203 | 39.51 |
01:17 ET | 8233 | 40.025 |
01:19 ET | 1950 | 40 |
01:21 ET | 3545 | 40.01 |
01:24 ET | 4357 | 39.95 |
01:26 ET | 1439 | 39.955 |
01:28 ET | 1700 | 39.965 |
01:30 ET | 4234 | 39.875 |
01:32 ET | 17086 | 40.0855 |
01:33 ET | 5388 | 40 |
01:35 ET | 2394 | 39.95 |
01:37 ET | 10650 | 39.96 |
01:39 ET | 2781 | 39.905 |
01:42 ET | 1325 | 39.9161 |
01:44 ET | 4697 | 39.83 |
01:46 ET | 1401 | 39.805 |
01:48 ET | 4305 | 39.82 |
01:50 ET | 3700 | 39.8532 |
01:51 ET | 3600 | 39.8 |
01:53 ET | 17531 | 39.386 |
01:55 ET | 1600 | 39.45 |
01:57 ET | 9255 | 39.425 |
02:00 ET | 5056 | 39.435 |
02:02 ET | 4250 | 39.68 |
02:04 ET | 9948 | 39.745 |
02:06 ET | 1499 | 39.81 |
02:08 ET | 7692 | 39.89 |
02:09 ET | 12410 | 39.95 |
02:11 ET | 61335 | 39.9 |
02:13 ET | 2000 | 39.9 |
02:15 ET | 4100 | 39.75 |
02:18 ET | 1600 | 39.855 |
02:20 ET | 1251 | 39.86 |
02:22 ET | 2118 | 39.85 |
02:24 ET | 1737 | 39.855 |
02:26 ET | 900 | 39.865 |
02:27 ET | 4552 | 39.885 |
02:29 ET | 2757 | 39.9 |
02:31 ET | 4727 | 39.81 |
02:33 ET | 6521 | 39.73 |
02:36 ET | 3200 | 39.84 |
02:38 ET | 2650 | 40.085 |
02:40 ET | 3588 | 39.99 |
02:42 ET | 13370 | 40.07 |
02:44 ET | 4170 | 40.04 |
02:45 ET | 2244 | 40.05 |
02:47 ET | 3347 | 40 |
02:49 ET | 2202 | 40.035 |
02:51 ET | 57925 | 40.105 |
02:54 ET | 900 | 40.105 |
02:56 ET | 1400 | 40.105 |
02:58 ET | 4110 | 40 |
03:00 ET | 2625 | 39.995 |
03:02 ET | 6950 | 39.925 |
03:03 ET | 3949 | 39.835 |
03:05 ET | 1900 | 39.84 |
03:07 ET | 9813 | 39.98 |
03:09 ET | 1620 | 39.9525 |
03:12 ET | 1579 | 39.95 |
03:14 ET | 1250 | 39.96 |
03:16 ET | 2250 | 39.96 |
03:18 ET | 3050 | 39.785 |
03:20 ET | 4781 | 39.76 |
03:21 ET | 3628 | 39.575 |
03:23 ET | 2577 | 39.38 |
03:25 ET | 20477 | 39.36 |
03:27 ET | 4179 | 39.5 |
03:30 ET | 3052 | 39.54 |
03:32 ET | 5781 | 39.82 |
03:34 ET | 3100 | 39.905 |
03:36 ET | 8550 | 39.81 |
03:38 ET | 3777 | 39.805 |
03:39 ET | 7508 | 39.93 |
03:41 ET | 4635 | 39.9 |
03:43 ET | 16193 | 39.96 |
03:45 ET | 2548 | 40.01 |
03:48 ET | 10130 | 39.995 |
03:50 ET | 15265 | 39.89 |
03:52 ET | 17672 | 40.03 |
03:54 ET | 13971 | 40 |
03:56 ET | 21867 | 39.87 |
03:57 ET | 13532 | 39.84 |
03:59 ET | 33464 | 39.96 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.3B | -17.2x | --- |
Apogee Therapeutics Inc | 2.2B | -18.3x | --- |
Iovance Biotherapeutics Inc | 2.4B | -4.7x | --- |
Rocket Pharmaceuticals Inc | 2.2B | -8.3x | --- |
Celldex Therapeutics Inc | 2.4B | -12.7x | --- |
Janux Therapeutics Inc | 2.2B | -33.9x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -17.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.